Genetic variations in MicroRNA genes and cancer risk: A field synopsis and meta-analysis.
Por:
Park JH, Jeong GH, Lee KS, Lee KH, Suh JS, Eisenhut M, van der Vliet HJ, Kronbichler A, Stubbs B, Solmi M, Dragioti E, Koyanagi A, Shin JI and Gamerith G
Publicada:
1 abr 2020
Ahead of Print:
26 ene 2020
Resumen:
Cancer risk has been associated with certain gene variations in microRNA (miRNA), but conflicting evidence warrants re-assessing of significant results in meta-analyses. We summarized published meta-analyses that assess the associations between miRNA polymorphism and cancers to show the validity of the findings.
Filiaciones:
Park JH:
Yonsei University College of Medicine, Severance Hospital, Seoul, Korea
Jeong GH:
College of Medicine, Gyeongsang National University, Jinju, Korea
Lee KS:
Yonsei University College of Medicine, Severance Hospital, Seoul, Korea
Lee KH:
Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea
Division of Pediatric Nephrology, Severance Children's Hospital, Seoul, Korea
Institute of Kidney Disease Research, Yonsei University College of Medicine, Seoul, Korea
Suh JS:
Department of Pediatrics, The Catholic University of Korea College of Medicine, Seoul, Korea
Eisenhut M:
Luton &, Dunstable University Hospital NHS Foundation Trust, Luton, United Kingdom
van der Vliet HJ:
Department of Medical Oncology, UMC, Cancer Center Amsterdam, VU University, Amsterdam, The Netherlands
Kronbichler A:
Department of Internal Medicine IV (Nephrology), Medical University of Innsbruck, Innsbruck, Austria
Stubbs B:
Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London, United Kingdom
South London and Maudsley NHS Foundation Trust, Denmark Hill, London, United Kingdom
Faculty of Health, Social Care and Education, Anglia Ruskin University, Chelmsford, United Kingdom
Solmi M:
Department of Neuroscience, University of Padova, Padova, Italy
Dragioti E:
Pain and Rehabilitation Centre, and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden
Koyanagi A:
Parc Sanitari Sant Joan de Déu/CIBERSAM, Universitat de Barcelona, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
Shin JI:
Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea
Division of Pediatric Nephrology, Severance Children's Hospital, Seoul, Korea
Institute of Kidney Disease Research, Yonsei University College of Medicine, Seoul, Korea
Gamerith G:
Department of Internal Medicine V (Hematology and Oncology), Medical University of Innsbruck, Innsbruck, Austria
Tyrolean Cancer Research Institute, Innsbruck, Austria
Bronze
|